• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Hundreds Were Mistakenly Told They Might Have Cancer, Test Company Says

Grail, which makes a blood test for cancer, said a vendor’s software issue caused inaccurate letters to be sent to about 400 customers last month.

Amanda Holpuch
Author: Amanda Holpuch

Written by

Amanda Holpuch

in

Antitrust Laws and Competition Issues, Cancer, Federal Trade Commission, Grail Inc, Illumina Inc, Mergers, Acquisitions and Divestitures, Tests (Medical)
←Saudi Arabia Says It Will Cut Production to Stem a Slide in Oil Prices
Lily-Rose Depp Reveals She Tries To ‘Steer Clear’ Of The Weeknd On ‘The Idol’ Set→

More posts

  • How Doku became key player for treble-chasing Man City

  • The Eurovision Song Contest reaches its grand final with pop and protests

  • Trump says Islamic State group leader was killed in a joint US-Nigerian mission

  • Would FA Cup win paper over the cracks for Chelsea?

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube